Calendar

Date TBD

RECRUITINGphase readoutNCT05848765: Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy

Sponsor: University of Birmingham. Phase: PHASE2. Conditions: Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma

full page →ctgov ↗

RECRUITINGphase readoutNCT06722365: Characterization of Fetal Lung With Quantitative Ultrasound

Sponsor: University of Wisconsin, Madison. Phase: . Conditions: Respiratory Complication, Fetal Lung Imaging

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05780567: Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Phase: PHASE3. Conditions: Breast Cancer

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04708067: Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Locally Advanced Intrahepatic Cholangiocarcinoma, Metastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8, Stage IV Intrahepatic Cholangiocarcinoma AJCC v8

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07318467: Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin Alone

Sponsor: Cairo University. Phase: NA. Conditions: Post Partum Hemorrhage

full page →ctgov ↗

RECRUITINGphase readoutNCT05666167: Expanding Exercise Programming for Veterans Through Telehealth

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Arthritis

full page →ctgov ↗

RECRUITINGphase readoutNCT07153367: Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE)

Sponsor: Centre Hospitalier Intercommunal Creteil. Phase: PHASE2. Conditions: Infertility, Insemination

full page →ctgov ↗

RECRUITINGphase readoutNCT02682667: Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Multiple Myeloma, Lymphoma, Non-Hodgkin, Leukemia-Lymphoma, Adult T-Cell, Hodgkin Disease, Non-Small Cell Lung Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT07385300: Omega-3 Pufa and Aspirin as Adjunctive Therapy in Treatment of Smoker Patients With Stage Iii Periodontitis

Sponsor: Alexandria University. Phase: NA. Conditions: Periodontitis, Diabete Mellitus

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07382700: Metabolic Characteristics of Plasma OxPLs in STEMI Patients.

Sponsor: First Affiliated Hospital of Ningbo University. Phase: . Conditions: STEMI - ST-segment Elevation Myocardial Infarction

full page →ctgov ↗

RECRUITINGphase readoutNCT07326007: Verbal Analgesia Versus Standard Technique for Pain Control During Copper T380A Intrauterine Device Insertion in Women With Previous Cesarean Delivery

Sponsor: Cairo University. Phase: NA. Conditions: Contraception

full page →ctgov ↗

COMPLETEDphase readoutNCT00698607: Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing

Sponsor: Seoul National University Hospital. Phase: PHASE4. Conditions: Coronary Artery Disease

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07538492: Clinical Validation of an Artificial Intelligence-Based G-FAST Score in Patients With Stroke

Sponsor: Xuanwu Hospital, Beijing. Phase: . Conditions: Stroke

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05034536: PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma

Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Metastatic Melanoma

full page →ctgov ↗

RECRUITINGphase readoutNCT06980636: A Trial of Shengmai Liquid for Long COVID Fatigue.

Sponsor: Beijing University of Chinese Medicine. Phase: PHASE4. Conditions: Long COVID Fatigue

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06603311: Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection

Sponsor: Hannover Medical School. Phase: NA. Conditions: Compensated Liver Disease (Disorder), Hepatitis D, Chronic

full page →ctgov ↗

RECRUITINGphase readoutNCT06043011: Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms

Sponsor: iOMEDICO AG. Phase: . Conditions: Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), Waldenström's Macroglobulinemia (WM)

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04204811: Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: NA. Conditions: Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Carcinoma, Fallopian Tube Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT04943211: Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging

Sponsor: Anna Raciborska. Phase: PHASE3. Conditions: Histiocytosis

full page →ctgov ↗

RECRUITINGphase readoutNCT07228611: Assesment and Comparison of Osteoporosis Risk Factors After Stroke

Sponsor: Ankara Etlik City Hospital. Phase: . Conditions: Stroke Osteoporosis

full page →ctgov ↗

RECRUITINGphase readoutNCT07302971: Telemedicine-supported Management for Acute Ischemic Stroke

Sponsor: Capital Medical University. Phase: NA. Conditions: Acute Ischemic Stroke

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06768671: An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

Sponsor: MoonLake Immunotherapeutics AG. Phase: PHASE3. Conditions: Hidradenitis Suppurativa

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT00185744: Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

Sponsor: Stanford University. Phase: NA. Conditions: Breast Cancer, Carcinoma, Ductal

full page →ctgov ↗

RECRUITINGphase readoutNCT07382544: Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Advanced Cancer, Solid Tumor

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07342244: Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Sponsor: Donghua Zhang. Phase: NA. Conditions: AML, AML (Acute Myeloid Leukemia)

full page →ctgov ↗

RECRUITINGphase readoutNCT07121244: A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer

Sponsor: Radionetics Oncology. Phase: PHASE1. Conditions: Locoregionally Recurrent Hormone-receptor Positive Breast Cancer, Metastatic Hormone Receptor Positive Breast Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT02346734: Physical Telerehabilitation in Veterans With Multiple Sclerosis

Sponsor: University of Maryland, Baltimore. Phase: NA. Conditions: Multiple Sclerosis

full page →ctgov ↗

COMPLETEDphase readoutNCT03354234: Evaluation of the ORTHO-LBNP System

Sponsor: Military Institute of Aviation Medicine. Phase: NA. Conditions: Orthostatic Hypotension, Ischemia, Hypoxia

full page →ctgov ↗

COMPLETEDphase readoutNCT01619709: Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage

Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Intracerebral Hemorrhage

full page →ctgov ↗

TERMINATEDphase readoutNCT04057664: A Group Therapy Based on the Bio-psycho-social Treatment Approach for Women With Chronic Pelvic and Chronic Belly Pain

Sponsor: Swiss Paraplegic Research, Nottwil. Phase: . Conditions: Pain, Chronic, Pain, Pelvic, Pain, Abdominal, Depression, Sex Disorder, Endometriosis

full page →ctgov ↗

RECRUITINGphase readoutNCT06282809: The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy

Sponsor: HistoSonics, Inc.. Phase: NA. Conditions: Pancreas Cancer, Adenocarcinoma of the Pancreas, Pancreatic Cancer, Tumor of Pancreas

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07342309: Real-World Treatment Patterns and Outcomes in HER2-Altered Metastatic Breast Cancer Patients in the United States

Sponsor: Boehringer Ingelheim. Phase: . Conditions: Metastatic Breast Cancer

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07490899: Combined Nutrition and Parenting Study

Sponsor: University of South Carolina. Phase: PHASE3. Conditions: Early Childhood Development (ECD)

full page →ctgov ↗

COMPLETEDphase readoutNCT07119099: The relatıonshıp Between Upper Extremity Exercise Test and Exercise Capacity ın patıents wıth Idiopathic Pulmonary Fibrosis

Sponsor: Marmara University. Phase: . Conditions: Idiopathic Pulmonary Fibrosis (IPF)

full page →ctgov ↗

RECRUITINGphase readoutNCT07260799: Clinical Performance of Capillary Blood Samples Collected Using the Tasso+ Serum Gel Capillary Blood Collection System for Clinical Chemistry Testing of 14 Analytes on an Abbott Alinity Analyzer

Sponsor: Tasso Inc.. Phase: . Conditions: Serum Analytes

full page →ctgov ↗

RECRUITINGphase readoutNCT07244432: Post-ERCP Pancreatitis - Prophylactic Measures Implementation Study (PEP-PROMIS)

Sponsor: Branislav Kuncak. Phase: . Conditions: Pancreatitis, Acute, ERCP, Prophylaxis

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06299098: A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE2. Conditions: Obesity

full page →ctgov ↗

RECRUITINGphase readoutNCT05030298: Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial

Sponsor: Mayo Clinic. Phase: PHASE1. Conditions: Malignant Glioma

full page →ctgov ↗

COMPLETEDphase readoutNCT04087798: Controlling Hypertension Through Education and Coaching in Kidney Disease

Sponsor: University of Michigan. Phase: NA. Conditions: Chronic Kidney Diseases, Chronic Disease, Chronic Kidney Disease, Stage 3 (Moderate), Chronic Kidney Disease, Stage 4 (Severe), Chronic Kidney Disease Stage 5, Hypertension

full page →ctgov ↗

RECRUITINGphase readoutNCT07361263: Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency

Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: AVP Deficiency, Diabetes Insipidus

full page →ctgov ↗

COMPLETEDphase readoutNCT07052487: Effectiveness of Post Isometric Relaxation Technique Versus Simple Stretching Exercises for Pain and Physical Activity in Young Females With Primary Dysmenorrhea in Peshawar

Sponsor: Khyber Medical University Peshawar. Phase: NA. Conditions: Dysmenorrhea, Menstrual Pain

full page →ctgov ↗

RECRUITINGphase readoutNCT05755087: Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma

Sponsor: Lapo Alinari. Phase: PHASE1. Conditions: Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements, Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type, Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements, Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05660187: VIRtual Versus UsuAL In-office Care for Multiple Sclerosis (VIRTUAL-MS)

Sponsor: The Cleveland Clinic. Phase: NA. Conditions: Multiple Sclerosis

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07214987: PDT For Induction Therapy For Head And Neck Cancer

Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Squamous Cell Carcinoma, Head and Neck Cancer Squamous Cell Carcinoma, Head and Neck Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT04640987: Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback

Sponsor: Porteus, Matthew, MD. Phase: PHASE1. Conditions: Hematologic Diseases

full page →ctgov ↗

RECRUITINGphase readoutNCT07547787: A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)

Sponsor: Akeso. Phase: . Conditions: Locally Advanced Unresectable or Metastatic Gastric Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07470593: Study of Glucose Tolerance Abnormalities Using Continuous Glucose Monitoring for the Identification of Early Loss of Pancreatic Islet Graft Function.

Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Type 1 Diabetes (T1D)

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07094893: Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status

Sponsor: Gruppo Oncologico del Nord-Ovest. Phase: PHASE4. Conditions: Colorectal Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT06044493: MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients

Sponsor: Chong Kun Dang Pharmaceutical. Phase: PHASE4. Conditions: Kidney Transplant

full page →ctgov ↗

COMPLETEDphase readoutNCT05411393: Synergizing Home Health Rehabilitation Therapy

Sponsor: University of Florida. Phase: NA. Conditions: Frailty, Frail Elderly, Occupational Therapy, Activities of Daily Living, Home Health Care, Functional Status, Physical Functional Performance, Rehabilitation, Treatment Outcome, Health Services for the Aged

full page →ctgov ↗

Date TBD